FDA advertising/information "censorship" hearing planned by Barton's Oversight Subcommittee Nov. 29.
Executive Summary
FDA INFORMATION DISSEMINATION POLICIES WILL BE SUBJECT OF NOV. 29 HEARING before Rep. Barton's (R-Tex.) House Commerce/Oversight Subcommittee. The hearing will examine agency regulation of promotions for both off-label and approved uses. The subcommittee plans to invite testimony from Commissioner Kessler and Deputy Commissioner for Policy William Schultz, as well as other FDA officials and industry representatives.